Bromocriptine Mesylate Tablet
Product Images NDC 70518-4628

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 70518-4628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Bromocriptine Mesylate 2.5mg 70518 4628 00)

This is a description of a medication named Bromocriptine Mesylate manufactured by Padagis in Allegan, Mi. The tablets are in 2.5 mg strength and are meant to be kept out of reach of children. The usual dosage information can be found in the provided insert. It should be stored at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). Each box contains 50 tablets. The medication is round and white in color. It has been repackaged by RemedyRepack Inc. and is only available by prescription.*

FDA Label Image

Remedy_label (Remedy Label)

Description: This is the packaging information for Bromocriptine Mesylate 2.5mg tablets. It includes details such as quantity, NDC number, manufacturer, storage instructions, and a reminder to keep the medication out of reach of children. The tablets are round and white in color. The lot number and expiration date are not provided. The product has been repackaged by RemedyRepack Inc. in Indiana, PA. For dosage information, the insert should be consulted. It is for prescription use only.*

FDA Label Image

Structural Formula (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.